SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-004948
Filing Date
2023-02-28
Accepted
2023-02-28 17:23:53
Documents
1
Period of Report
2023-02-24

Document Format Files

Seq Description Document Type Size
1 230228 FORM 4 (OLWILL) rdgdoc.html 4  
1 230228 FORM 4 (OLWILL) rdgdoc.xml 4 3673
  Complete submission text file 0001437749-23-004948.txt   5166
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Olwill Shane (Reporting) CIK: 0001875416 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 23687499